Bipolar Disorder Therapeutics Global Market Report 2025
상품코드:1821536
리서치사:The Business Research Company
발행일:On Demand Report
페이지 정보:영문 250 Pages
라이선스 & 가격 (부가세 별도)
ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.
한글목차
양극성 장애 치료제 시장 규모는 향후 수년간 강력한 성장이 전망됩니다. 2029년에는 CAGR 5.9%로 98억 2,000만 달러로 성장합니다. 예측 기간의 성장은 양극성 장애의 유병률 증가, 정부의 구상, 의료 인프라 확대, 좌식 생활습관 채택 증가 등에 기인하는 것으로 보입니다. 예측 기간의 주요 동향으로는 개인 맞춤형 치료 접근법, 디지털 헬스 통합, 혁신적 약물 치료, 예방적 개입, 신경영상, 바이오마커 등이 있습니다.
향후 5년간 5.9%의 성장률 전망은 지난번 전망치보다 0.2% 소폭 하락한 수치입니다. 이 감소는 주로 미국과 다른 국가 간의 관세의 영향에 기인합니다. 관세 장벽은 인도와 이스라엘에서 조달하는 기분안정제 및 항정신병제물의 비용을 상승시킴으로써 미국의 정신의료를 저해하고, 치료 순응도를 낮추며, 정신과 의료비를 상승시킬 것으로 예측됩니다. 또한 상호 관세와 무역 긴장과 제한 증가로 인한 세계 경제와 무역에 대한 악영향으로 인해 그 영향은 더욱 광범위하게 나타날 것으로 보입니다.
헬스케어 지출 증가는 향후 양극성 장애 치료제 시장의 성장을 촉진할 것으로 예측됩니다. 의료 인프라에는 의료, 예방 대책, 공중 보건 활동, 재활, 지역 보건 활동, 건강 조사 등과 관련된 모든 비용이 포함됩니다. 의료비 지출 증가에는 고령화, 만성질환의 급증, 약제비 상승 등 의료 서비스 및 치료에 대한 수요를 크게 증가시키는 몇 가지 요인이 있습니다. 정신건강 문제에 대한 인식이 높아짐에 따라 양극성 장애 진단도 증가하고 있으며, 이에 따라 치료적 개입에 대한 수요도 증가하고 있습니다. 예를 들어 2023년 11월 캐나다에 본부를 둔 비영리단체인 Canadian Institute for Health Information은 2022년 1.5%의 완만한 성장에 이어 2023년에는 캐나다의 총 의료비가 2.8% 증가할 것으로 예측했습니다. 이처럼 의료비 지출 증가가 양극성 장애 치료제 시장의 성장을 촉진하고 있습니다.
목차
제1장 개요
제2장 시장의 특징
제3장 시장 동향과 전략
제4장 시장 : 금리, 인플레이션, 지정학, 무역 전쟁과 관세 및 Covid와 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오
제5장 세계의 성장 분석과 전략 분석 프레임워크
세계의 양극성 장애 치료제 : PESTEL 분석(정치, 사회, 기술, 환경, 법적 요인, 촉진요인과 억제요인)
최종 용도 산업의 분석
세계의 양극성 장애 치료제 시장 : 성장률 분석
세계의 양극성 장애 치료제 시장 실적 : 규모와 성장, 2019-2024
세계의 양극성 장애 치료제 시장 예측 : 규모와 성장, 2024-2029, 2034F
세계의 양극성 장애 치료제 : TAM(Total Addressable Market)
제6장 시장 세분화
세계의 양극성 장애 치료제 시장 : 약제 클래스별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
기분 안정제
항정신병약
항우울제
기타 약물
세계의 양극성 장애 치료제 시장 : 기구별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
선택적 세로토닌 재흡수 저해제
세로토닌-노르에피네프린 재흡수 저해제
삼환계 항우울제
모노아민 산화 효소 저해제
벤조디아제핀
베타 차단약
기타 메커니즘
세계의 양극성 장애 치료제 시장 : 유통 채널별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
병원 약국
소매 약국
온라인 약국
세계의 양극성 장애 치료제 시장 : 서브 세분화, 기분 안정제(약제 클래스별), 실적과 예측, 2019-2024, 2024-2029F, 2034F
리튬
항경련약
칼슘 채널 차단약
세계의 양극성 장애 치료제 시장 : 서브 세분화, 항정신병약(약제 클래스별), 실적과 예측, 2019-2024, 2024-2029F, 2034F
비정형 항정신병약
정형 항정신병약
세계의 양극성 장애 치료제 시장 : 서브 세분화, 항우울제(약제 클래스별), 실적과 예측, 2019-2024, 2024-2029F, 2034F
선택적 세로토닌 재흡수 저해제(SSRI)
세로토닌-노르에피네프린 재흡수 저해제(SNRI)
삼환계 항우울제(TCA)
세계의 양극성 장애 치료제 시장 : 서브 세분화, 기타 약물(약제 클래스별), 실적과 예측, 2019-2024, 2024-2029F, 2034F
벤조디아제핀
보조 요법
허브 보충제
제7장 지역별·국가별 분석
세계의 양극성 장애 치료제 시장 : 지역별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
세계의 양극성 장애 치료제 시장 : 국가별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
제8장 아시아태평양 시장
제9장 중국 시장
제10장 인도 시장
제11장 일본 시장
제12장 호주 시장
제13장 인도네시아 시장
제14장 한국 시장
제15장 서유럽 시장
제16장 영국 시장
제17장 독일 시장
제18장 프랑스 시장
제19장 이탈리아 시장
제20장 스페인 시장
제21장 동유럽 시장
제22장 러시아 시장
제23장 북미 시장
제24장 미국 시장
제25장 캐나다 시장
제26장 남미 시장
제27장 브라질 시장
제28장 중동 시장
제29장 아프리카 시장
제30장 경쟁 구도와 기업 개요
양극성 장애 치료제 시장 : 경쟁 구도
양극성 장애 치료제 시장 : 기업 개요
AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis
Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
Astellas Pharma Inc Overview, Products and Services, Strategy and Financial Analysis
AstraZeneca PLC Overview, Products and Services, Strategy and Financial Analysis
Bristol-Myers Squibb Overview, Products and Services, Strategy and Financial Analysis
제31장 기타 대기업과 혁신적 기업
GlaxoSmithKline PLC
Januaryssen Pharmaceuticals
Novartis AG
Otsuka Pharmaceutical Co. Ltd.
Validus Pharmaceuticals
Eli Lilly and Company
Gedeon Richter PLC.
Sumitomo Pharma Co. Ltd
H. Lundbeck A/S
Janssen Pharmaceuticals
Sanofi S.A.
Lundbeck A/S
Allergan plc
Takeda Pharmaceutical Company Limited
Sunovion Pharmaceuticals Inc.
제32장 세계의 시장 경쟁 벤치마킹과 대시보드
제33장 주요 합병과 인수
제34장 최근 시장 동향
제35장 시장의 잠재력이 높은 국가, 부문, 전략
양극성 장애 치료제 시장 2029 : 새로운 기회를 제공하는 국가
양극성 장애 치료제 시장 2029 : 새로운 기회를 제공하는 부문
양극성 장애 치료제 시장 2029 : 성장 전략
시장 동향에 기반한 전략
경쟁사 전략
제36장 부록
KSA
영문 목차
영문목차
Bipolar disorder therapeutics consist of medications such as mood stabilizers, antidepressants, antipsychotics, and psychological counseling aimed at controlling symptoms associated with bipolar disorders. These therapeutics play a crucial role in the treatment and management of bipolar disorders.
The primary categories of drugs within bipolar disorder therapeutics include mood stabilizers, antipsychotic drugs, antidepressant drugs, and other medications. Mood stabilizers constitute a class of drugs specifically designed for the management and treatment of bipolar disorders. Various mechanisms are employed, including selective serotonin reuptake inhibitors, serotonin-norepinephrine reuptake inhibitors, tricyclic antidepressants, monoamine oxidase inhibitors, benzodiazepines, beta-blockers, and others. These drugs are commonly available through hospital pharmacies, retail pharmacies, and online pharmacies.
Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.
The sharp rise in U.S. tariffs and the resulting trade tensions in spring 2025 are having a significant impact on the healthcare sector, especially in the supply of essential medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are grappling with higher costs for imported surgical tools, imaging systems, and consumables like syringes and catheters, many of which have limited domestic substitutes. These escalating expenses are putting pressure on healthcare budgets, prompting some providers to delay equipment upgrades or pass increased costs on to patients. Furthermore, tariffs on raw materials and components are disrupting the manufacturing of vital drugs and devices, leading to supply chain delays. In response, the industry is adopting diversified sourcing strategies, expanding local production where feasible, and pushing for tariff exemptions on critical medical products.
The bipolar disorder therapeutics market research report is one of a series of new reports from The Business Research Company that provides bipolar disorder therapeutics market statistics, including bipolar disorder therapeutics industry global market size, regional shares, competitors with a bipolar disorder therapeutics market share, detailed bipolar disorder therapeutics market segments, market trends and opportunities, and any further data you may need to thrive in the bipolar disorder therapeutics industry. This bipolar disorder therapeutics market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The bipolar disorder therapeutics market size has grown strongly in recent years. It will grow from $7.44 billion in 2024 to $7.82 billion in 2025 at a compound annual growth rate (CAGR) of 5.1%. The growth in the historic period can be attributed to rise in medical research and developments, increased healthcare expenditure, rise in prevalence of mental health disorders, rise in patient advocacy.
The bipolar disorder therapeutics market size is expected to see strong growth in the next few years. It will grow to $9.82 billion in 2029 at a compound annual growth rate (CAGR) of 5.9%. The growth in the forecast period can be attributed to increasing prevalence of bipolar disorder, government initiatives, expansion of healthcare infrastructure, growing adoption of a sedentary lifestyle. Major trends in the forecast period include personalized treatment approaches, digital health integration, innovative medications, preventive interventions, neuroimaging and biomarkers.
The forecast of 5.9% growth over the next five years reflects a slight reduction of 0.2% from the previous projection. This reduction is primarily due to the impact of tariffs between the US and other countries. Tariff barriers are expected to hamper U.S. mental healthcare by increasing the cost of mood stabilizers and antipsychotic medications sourced from India and Israel, thereby reducing treatment adherence and elevating psychiatric care expenditures. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.
The rising healthcare expenditure is projected to drive the growth of the bipolar disorder therapeutics market in the future. Healthcare infrastructure encompasses all expenses related to medical care, preventive measures, public health initiatives, rehabilitation, community health activities, and health research. Several factors contribute to the increase in healthcare spending, including an aging population, a surge in chronic diseases, and escalating drug costs, all of which significantly heighten the demand for medical services and treatments. As awareness of mental health issues grows, the diagnosis of bipolar disorder is also on the rise, resulting in greater demand for therapeutic interventions. For example, in November 2023, the Canadian Institute for Health Information, a non-profit organization based in Canada, projected that total health spending in Canada would increase by 2.8% in 2023, following a modest growth of just 1.5% in 2022. Thus, the increasing healthcare expenditure is fueling the growth of the bipolar disorder therapeutics market.
The growing demand for psychological counseling is expected to significantly contribute to the expansion of the bipolar disorder therapeutics market. Psychological counseling, a form of therapy aimed at improving mental health and enhancing overall quality of life, plays a crucial role in managing symptoms of bipolar disorder. Psychotherapy helps individuals identify triggers for bipolar episodes and equips them with coping mechanisms for stressors. According to The Centers for Disease Control and Prevention (CDC), from 2019 to 2021, there was an increase in the percentages of both men and women aged 18-44 in the U.S. who received any mental health treatment in the past 12 months. The surge in demand for psychological counseling underscores a critical aspect of bipolar disorder therapeutics, driving the market forward.
Strategic partnerships have become a prominent trend in the bipolar disorder therapeutics market. Major companies in this sector are increasingly focusing on collaborations to strengthen their market position. For example, in April 2022, BioXcel Therapeutics, Inc., a biopharmaceutical company based in the US, received FDA approval for IGALMITM (dexmedetomidine), a sublingual film designed for the acute treatment of agitation associated with schizophrenia or bipolar I or II disorder in adults. This film dissolves in the mouth and is specifically formulated to address mild, moderate, or severe agitation in these patient groups. The drug is engineered for rapid onset of action, allowing for effective management of agitation episodes.
Major companies in the Bipolar Disorder Therapeutics and related market are focusing on developing new treatments for depressive episodes linked to bipolar I or II disorder in order to reach larger customer bases, boost sales, and increase revenue. Among the various types of bipolar disorders, bipolar depression represents the most common and severe clinical manifestation. Compared to manic or hypomanic episodes, these depressive episodes are associated with a worse prognosis, longer duration, and more frequent recurrences. For example, in March 2024, the EDIT-B consortium, a collaborative organization based in France that specializes in innovative diagnostic tools and biomarkers, launched myEDIT-B, a novel blood diagnostic tool designed to provide objective biological data to assist psychiatrists and healthcare professionals in making accurate diagnoses. This tool analyzes RNA editing-based biomarkers and has demonstrated sensitivity and specificity rates exceeding 80%. By enabling faster and more precise diagnoses-potentially reducing wait times to within four weeks-myEDIT-B aims to address the significant issue of misdiagnosis in mental health, with approximately 40% of individuals diagnosed with depression possibly having bipolar disorder instead.
In June 2023, Brain Therapeutics, a Greece-based central nervous system specialty company, made a strategic move by acquiring the prescription drug brand Lazap (olanzapine) from the Greek pharmaceutical company Lyofin Ltd., the terms of which were undisclosed. This acquisition, facilitated by Brain Therapeutics, aims to broaden Neuraxpharm Group's therapeutic product portfolio in Greece and Europe. The agreement positions Neuraxpharm Group to leverage its expertise in the central nervous system (CNS) field, ensuring that Lazap reaches a wider audience. Lyofin Ltd., the Greek pharmaceutical company, is a key player in this collaboration, contributing to the expansion of Neuraxpharm Group's offerings in the CNS therapeutic domain. This strategic move reflects the industry's dedication to meeting healthcare demands by enhancing its product portfolio and geographical reach.
Major companies operating in the bipolar disorder therapeutics market include AbbVie Inc., Pfizer Inc., Astellas Pharma Inc, AstraZeneca PLC, Bristol-Myers Squibb, GlaxoSmithKline PLC, Januaryssen Pharmaceuticals, Novartis AG, Otsuka Pharmaceutical Co. Ltd., Validus Pharmaceuticals, Eli Lilly and Company, Gedeon Richter PLC., Sumitomo Pharma Co. Ltd, H. Lundbeck A/S, Janssen Pharmaceuticals, Sanofi S.A., Lundbeck A/S, Allergan plc, Takeda Pharmaceutical Company Limited, Sunovion Pharmaceuticals Inc., Alkermes plc, Mylan N.V., Teva Pharmaceutical Industries Ltd., Johnson & Johnson, Celon Pharma SA, NeuroRx Inc., IntraCellular Therapies Inc., Sumitomo Pharma Co. Ltd., Vanda Pharmaceuticals Inc., Sage Therapeutics Inc.
North America was the largest region in the bipolar disorder therapeutics market in 2024. Europe is expected to be the fastest-growing region in the forecast period. The regions covered in the bipolar disorder therapeutics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa.
The countries covered in the bipolar disorder therapeutics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA.
The bipolar disorder therapeutics market includes revenues earned by entities by family-focused therapy, interpersonal and social rhythm therapy, cognitive behavioral therapy and dialectical behavior therapy. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Bipolar Disorder Therapeutics Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on bipolar disorder therapeutics market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for bipolar disorder therapeutics ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The bipolar disorder therapeutics market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:
The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Scope
Markets Covered:1) By Drug Class: Mood Stabilizers; Antipsychotic Drugs; Antidepressant Drugs; Other Drugs
2) By Mechanism: Selective Serotonin Reuptake Inhibitors; Serotonin-norepinephrine Reuptake Inhibitors; Tricyclic Antidepressants; Monoamine Oxidase Inhibitors; Benzodiazepines; Beta-Blockers; Other Mechanisms
3) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies; Online Pharmacies
Subsegments:
1) By Mood Stabilizers: Lithium; Anticonvulsants; Calcium Channel Blockers
2) By Antipsychotic Drugs: Atypical Antipsychotics; Typical Antipsychotics
3. Bipolar Disorder Therapeutics Market Trends And Strategies
4. Bipolar Disorder Therapeutics Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market
4.1. Supply Chain Impact from Tariff War & Trade Protectionism
5. Global Bipolar Disorder Therapeutics Growth Analysis And Strategic Analysis Framework
5.1. Global Bipolar Disorder Therapeutics PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
5.2. Analysis Of End Use Industries
5.3. Global Bipolar Disorder Therapeutics Market Growth Rate Analysis
5.4. Global Bipolar Disorder Therapeutics Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
5.5. Global Bipolar Disorder Therapeutics Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
5.6. Global Bipolar Disorder Therapeutics Total Addressable Market (TAM)
6.1. Global Bipolar Disorder Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Mood Stabilizers
Antipsychotic Drugs
Antidepressant Drugs
Other Drugs
6.2. Global Bipolar Disorder Therapeutics Market, Segmentation By Mechanism, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Selective Serotonin Reuptake Inhibitors
Serotonin-norepinephrine Reuptake Inhibitors
Tricyclic Antidepressants
Monoamine Oxidase Inhibitors
Benzodiazepines
Beta-Blockers
Other Mechanisms
6.3. Global Bipolar Disorder Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
6.4. Global Bipolar Disorder Therapeutics Market, Sub-Segmentation Of Mood Stabilizers, By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Lithium
Anticonvulsants
Calcium Channel Blockers
6.5. Global Bipolar Disorder Therapeutics Market, Sub-Segmentation Of Antipsychotic Drugs, By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Atypical Antipsychotics
Typical Antipsychotics
6.6. Global Bipolar Disorder Therapeutics Market, Sub-Segmentation Of Antidepressant Drugs, By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
6.7. Global Bipolar Disorder Therapeutics Market, Sub-Segmentation Of Other Drugs, By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Benzodiazepines
Adjunctive Therapies
Herbal Supplements
7. Bipolar Disorder Therapeutics Market Regional And Country Analysis
7.1. Global Bipolar Disorder Therapeutics Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
7.2. Global Bipolar Disorder Therapeutics Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Bipolar Disorder Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.3. Asia-Pacific Bipolar Disorder Therapeutics Market, Segmentation By Mechanism, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.4. Asia-Pacific Bipolar Disorder Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
9. China Bipolar Disorder Therapeutics Market
9.1. China Bipolar Disorder Therapeutics Market Overview
9.2. China Bipolar Disorder Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.3. China Bipolar Disorder Therapeutics Market, Segmentation By Mechanism, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.4. China Bipolar Disorder Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
10. India Bipolar Disorder Therapeutics Market
10.1. India Bipolar Disorder Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.2. India Bipolar Disorder Therapeutics Market, Segmentation By Mechanism, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.3. India Bipolar Disorder Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11. Japan Bipolar Disorder Therapeutics Market
11.1. Japan Bipolar Disorder Therapeutics Market Overview
11.2. Japan Bipolar Disorder Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.3. Japan Bipolar Disorder Therapeutics Market, Segmentation By Mechanism, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.4. Japan Bipolar Disorder Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12. Australia Bipolar Disorder Therapeutics Market
12.1. Australia Bipolar Disorder Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.2. Australia Bipolar Disorder Therapeutics Market, Segmentation By Mechanism, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.3. Australia Bipolar Disorder Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13. Indonesia Bipolar Disorder Therapeutics Market
13.1. Indonesia Bipolar Disorder Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.2. Indonesia Bipolar Disorder Therapeutics Market, Segmentation By Mechanism, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.3. Indonesia Bipolar Disorder Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14. South Korea Bipolar Disorder Therapeutics Market
14.1. South Korea Bipolar Disorder Therapeutics Market Overview
14.2. South Korea Bipolar Disorder Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.3. South Korea Bipolar Disorder Therapeutics Market, Segmentation By Mechanism, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.4. South Korea Bipolar Disorder Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15. Western Europe Bipolar Disorder Therapeutics Market
15.1. Western Europe Bipolar Disorder Therapeutics Market Overview
15.2. Western Europe Bipolar Disorder Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.3. Western Europe Bipolar Disorder Therapeutics Market, Segmentation By Mechanism, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.4. Western Europe Bipolar Disorder Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16. UK Bipolar Disorder Therapeutics Market
16.1. UK Bipolar Disorder Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.2. UK Bipolar Disorder Therapeutics Market, Segmentation By Mechanism, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.3. UK Bipolar Disorder Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17. Germany Bipolar Disorder Therapeutics Market
17.1. Germany Bipolar Disorder Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.2. Germany Bipolar Disorder Therapeutics Market, Segmentation By Mechanism, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.3. Germany Bipolar Disorder Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18. France Bipolar Disorder Therapeutics Market
18.1. France Bipolar Disorder Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.2. France Bipolar Disorder Therapeutics Market, Segmentation By Mechanism, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.3. France Bipolar Disorder Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19. Italy Bipolar Disorder Therapeutics Market
19.1. Italy Bipolar Disorder Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.2. Italy Bipolar Disorder Therapeutics Market, Segmentation By Mechanism, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.3. Italy Bipolar Disorder Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20. Spain Bipolar Disorder Therapeutics Market
20.1. Spain Bipolar Disorder Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.2. Spain Bipolar Disorder Therapeutics Market, Segmentation By Mechanism, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.3. Spain Bipolar Disorder Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21. Eastern Europe Bipolar Disorder Therapeutics Market
21.1. Eastern Europe Bipolar Disorder Therapeutics Market Overview
21.2. Eastern Europe Bipolar Disorder Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.3. Eastern Europe Bipolar Disorder Therapeutics Market, Segmentation By Mechanism, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.4. Eastern Europe Bipolar Disorder Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22. Russia Bipolar Disorder Therapeutics Market
22.1. Russia Bipolar Disorder Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.2. Russia Bipolar Disorder Therapeutics Market, Segmentation By Mechanism, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.3. Russia Bipolar Disorder Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23. North America Bipolar Disorder Therapeutics Market
23.1. North America Bipolar Disorder Therapeutics Market Overview
23.2. North America Bipolar Disorder Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.3. North America Bipolar Disorder Therapeutics Market, Segmentation By Mechanism, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.4. North America Bipolar Disorder Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24. USA Bipolar Disorder Therapeutics Market
24.1. USA Bipolar Disorder Therapeutics Market Overview
24.2. USA Bipolar Disorder Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.3. USA Bipolar Disorder Therapeutics Market, Segmentation By Mechanism, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.4. USA Bipolar Disorder Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.2. Canada Bipolar Disorder Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.3. Canada Bipolar Disorder Therapeutics Market, Segmentation By Mechanism, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.4. Canada Bipolar Disorder Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26. South America Bipolar Disorder Therapeutics Market
26.1. South America Bipolar Disorder Therapeutics Market Overview
26.2. South America Bipolar Disorder Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.3. South America Bipolar Disorder Therapeutics Market, Segmentation By Mechanism, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.4. South America Bipolar Disorder Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27. Brazil Bipolar Disorder Therapeutics Market
27.1. Brazil Bipolar Disorder Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.2. Brazil Bipolar Disorder Therapeutics Market, Segmentation By Mechanism, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.3. Brazil Bipolar Disorder Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28. Middle East Bipolar Disorder Therapeutics Market
28.1. Middle East Bipolar Disorder Therapeutics Market Overview
28.2. Middle East Bipolar Disorder Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.3. Middle East Bipolar Disorder Therapeutics Market, Segmentation By Mechanism, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.4. Middle East Bipolar Disorder Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29. Africa Bipolar Disorder Therapeutics Market
29.1. Africa Bipolar Disorder Therapeutics Market Overview
29.2. Africa Bipolar Disorder Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.3. Africa Bipolar Disorder Therapeutics Market, Segmentation By Mechanism, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.4. Africa Bipolar Disorder Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
30. Bipolar Disorder Therapeutics Market Competitive Landscape And Company Profiles
